Objective To investigate the safety and feasibility of hepatic arterial embolization through abdominal aorta catheterization in rat liver cancer models.Methods Twenty Sprague-Dawley rat hepatocellular carcinoma models were successfully established by in situ implantation of McA-Rh7777 cells.The experimental rats were randomly divided into group A and group B,with 10 rats in each group.For the experimental rats of group A,catheterization of abdominal aorta was adopted to perform hepatic arterial angiography and embolization,while for the experimental rats of group B,the catheter passed through the gastroduodenal artery,then was retrogradely inserted into the proper hepatic artery to perform infusion of drugs,hepatic arterial angiography and embolization.The operation time,operation success rate,intraoperative and postoperative surgical complications in both groups were recorded.The postoperative recovery status of the experimental rats was recorded.The iodized oil deposition state was evaluated by abdominal CT scan at one day before operation and at 1,5 and 7 days after operation.Results In groups A and B,the operation time was(15.11±0.70)min and(34.39±1.60)min respectively(P=0.036),the operation success rate was 100％and 60％respectively(P=0.043),the differences between the two groups were statistically significant.No obvious surgical complications occurred in both groups.The postoperative CT plain scan showed that dense iodized oil deposition was observed in the experimental rats having successful operation.Conclusion Hepatic arterial embolization through abdominal aorta catheterization is a safe and feasible operation method for rat liver cancer models.

Objective To explore the correlation between glycolysis related indexes of peripheral blood mononuclear cells(PBMCs)[glucose transporter 1(GLUT1),fructose-2,6-diphosphatase 3(PFKFB3)and lactate kinase M2(PKM2)]and intracranial pressure and clinical prognosis of patients with hypertensive cerebral hemorrhage(HICH)who broke into the ventricle.Methods 85 HICH patients hospitalized in our hospital from January 2021 to June 2022 were retrospectively collected as the research participants.The levels of PKM2,GLUT1 and PFKFB3 in PBMCs were analyzed by enzyme-linked immunosorbent assay kit.Six months after the onset of HICH,the short-term outcome was evaluated by modified Rankin scale(mRS),and the patients were divided into good prognosis(mRS score≤2)and poor prognosis(mRS score≥3).Results The levels of PKM2,PFKFB3 and GLUT1 in PBMCs of HICH patients with ventricular rupture were further lower than those of the patients without ventricular rupture(P<0.05).Six months after discharge,8 patients(22.9%)with HICH in non-ventricular rupture group had poor prognosis,while 28 patients(56.0%)with HICH in ventricular rupture group had poor prognosis,and the difference was statistically significant(χ2=9.263,P=0.002).Compared with the group with good prognosis,the levels of PKM2 and GLUT1 in PBMCs of HICH patients with poor prognosis were lower(P<0.05).Compared with the good prognosis group,the levels of PKM2 and GLUT1 in PBMCs of HICH patients with poor prognosis group were lower in HICH patients with ventricular rupture(P<0.05).In HICH patients who broke into the ventricle,the AUC of PKM2 and GLUT1 in predicting the poor prognosis of HICH patients were 0.879(95%CI:0.807～0.951)and 0.897(95%CI:0.831～0.963),respectively.Conclusion The levels of PKM2 and GLUT1 in PBMCs of patients with HICH breaking into ventricles decrease significantly,and are negatively correlated with intracranial pressure,which can be used to predict the short-term prognosis of the patients.